Portfolio company
Fida Biosystems
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops biophysical analysis platforms for characterising proteins and nanoparticles, serving researchers, biotechnology firms, and pharmaceutical manufacturers to accelerate drug development.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Nanolyze AB
This company develops optical waveguide instruments for label-free nanoparticle analysis, providing researchers with tools to study nanomedicines and biological particles in real time.
Nplex Biosciences
This company develops high-throughput proteomics platforms for researchers in pharmaceutical and academic sectors to measure proteins for drug and biomarker discovery.
RNAnalytics
This company develops modular analysis toolkits and software for lipid nanoparticle characterisation to support biotech and pharmaceutical firms developing RNA-based therapies.
Creoptix
This company produces bioanalytical instruments for molecular interaction analysis for pharmaceutical firms and academic researchers conducting drug discovery and life sciences research.
Gyros AB
The company develops automated microfluidic immunoassay platforms and peptide synthesisers for biopharmaceutical manufacturers and contract research organisations to accelerate drug development.
LUMICKS
This company develops single-molecule and cell avidity analysis instruments for academic researchers and pharmaceutical companies to study biological mechanisms and develop life-saving therapies.
Refeyn
This company develops mass photometry instruments for biopharmaceutical firms and academic researchers to measure the molecular mass of single particles in solution.
Enantios
This company develops Raman optical activity measurement instruments and provides analytical services for pharmaceutical and chemical industries to characterise complex chiral molecules and biologics.
